VCCIS SIG - Business Meeting & Scientific Presentation
Limited to 40 participants. Register early as we are expected to sell out.
Join VCCIS for an evening of presentations over dinner and drinks. We have organized a wonderful interactive Special Interest Group meeting at the ACVIM Forum conference in Seattle Washington. Please contact us at info@vccis.org if you have trouble logging in.
Coming soon
Topic: Linking Microbiome Dysbiosis and Inflammation: Therapeutic Implications for Chronic Inflammatory Enteropathies
This program has been submitted, but not yet approved for two (2) hours of continuing education credit in jurisdictions that recognize RACE approval.
Speakers: Dr. Jan Suchodolski, DrVetMed, PhD, AGAF, DACVM and Dr. Linda Toresson DVM PhD
Location: Wild Ginger
1401 3rd Ave
Seattle WA 98101
Date: Thursday, June 11, 2026
Time: 6:30 - 9:30 pm Pacific
Menu
Coming soon
Parking
If you are staying near the convention center, there is no need to drive as the restaurant is only a short couple minute walk from the convention center, approximately 6 blocks.. You may also Uber, Lyft, or taxi to the restaurant. Street parking is tricky; nearby parking garages recommended offering variable parking rates:
Accessibility
Restroom and rooms / tables are ADA accessible. Wild Ginger provides elevator access to anyone who needs it.
Sponsor: Boehringer Ingelheim
Our program this evening is made possible with the generous support of Boehringer Ingelheim.
Program Details:
Topic: Linking Microbiome Dysbiosis and Inflammation: Therapeutic Implications for Chronic Inflammatory Enteropathies
Chronic inflammatory enteropathies (CE) occur very common in dogs and cats, and are frustrating to treat due to heterogenous treatment responses and lack of specific markers. The pathophysiology is complex and includes changes in the immune system, intestinal function, and the intestinal microbiome. The current classification based on treatment response (ie, food-, steroid-responsive) is currently being questioned, as new research findings indicate that CE is a progressive syndrome with many overlapping unspecific features, often due to chronic inflammation and irreversible mucosal remodeling, leading to changes in intestinal function and dysbiosis. The presentation will summarize novel research about the pathophysiology and novel concepts in multi-modal therapy, focusing on microbiome therapy, to these conditions. The presenter team will cover both findings from academic research and clinical experience from specialty practice in an interactive way.
Dr. Jan Suchodolski, DrVetMed, PhD, AGAF, DACVM
Dr. Jan S. Suchodolski is a professor, Purina PetCare Endowed Chair for Microbiome Research, associate director and head of microbiome sciences at the Gastrointestinal Laboratory at Texas A&M University. He received his DrVetMed from the University Vienna, Austria and his PhD in veterinary microbiology from Texas A&M University. He is board certified in immunology by the American College of Veterinary Microbiologists (ACVM). His research is focused on developing biomarkers for gastrointestinal disease and therapeutic approaches for the modulation of the intestinal microbiota. He has authored or co-authored more than 400 peer-reviewed articles in the area of veterinary gastroenterology and microbiome research. In 2024, he received the AVMA career achievement in canine research award.
Dr. Linda Toresson DVM PhD
Dr. Linda Toresson graduated from the Swedish University of Agricultural Science in 1995, became a Swedish Specialist in diseases of dogs and cats in 2002 and a Swedish Specialist in Small Animal Internal Medicine in 2007. She has combined clinical practice, focusing on gastroenterology, at a referral animal hospital in Sweden, with research throughout most of her career. In 2018, Linda defended her PhD in gastroenterology at Helsinki University on oral cobalamin supplementation in dogs with chronic enteropathies. She is currently a Post Doctoral Research Associate, focusing on fecal microbiota transplantation and bile acid diarrhea at the Gastrointestinal Laboratory at Texas A&M University in College Station, Texas, USA. She is the author of 20+ scientific papers and has contributed to several book chapters. Dr Toresson was a board member of the European Society of Comparative Gastroenterology from 2018-2024 and is a member of several advisory boards, including the Companion Animal Fecal Bank Consortium and the Scientific Committee of the Swedish Medical Product Agency.
To reserve a seat, you must RSVP with VCCIS directly. Click on the "Register Now" button (above) to RSVP.